Immunic Therapeutics
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies
Org chart
Dr. Daniel Vitt
CEO & President
Glenn Whaley
Vice President Finance, Principal Financial and Accounting Officer
Teams
View all
Discover similar companies
Novoheart
Irvine, United States
Cytovia Therapeutics
New York, United States
Life Biosciences
Boston, United States
HiberCell
New York, United States
miR Scientific
New York, United States
FBSciences
Collierville, United States
Enteris BioPharma
Boonton, United States
Coeus Consulting Group
Devon, United States
VantAI
New York, United States
Nanobeak Biotech
Redwood City, United States
Cohen Veterans Bioscience
Cambridge, United States
BioTeam
Middleton, United States
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.